Zisková marže společnosti QSAM Biosciences

Jaká je hodnota metriky Zisková marže společnosti QSAM Biosciences?

Hodnota metriky Zisková marže společnosti QSAM Biosciences, Inc. je 0.00%

Jaká je definice metriky Zisková marže?



Zisková marže (Profit margin) je procento čistého zisku z celkových tržeb.

Profit margin is calculated with the selling price (or revenue) taken as base times 100. It is the percentage of selling price that is turned into profit. Profit percentages are calculated to find the ratio of profit to cost of an investment. Profit margin is an indicator of a company's pricing strategies and how well it controls costs. Differences in competitive strategy and product mix cause the profit margin to vary among different companies. The profit margin is used mostly for internal comparisons. It is difficult to accurately compare the net profit ratio for different entities. Individual businesses' operating and financing arrangements vary so much that different entities are bound to have different levels of expenditure, so that comparison of one with another can have little meaning. A low profit margin indicates a low margin of safety: higher risk that a decline in sales will erase profits and result in a net loss, or a negative margin.

Zisková marže společností v sektoru Health Care sektor na OTC ve srovnání se společností QSAM Biosciences

Čemu se věnuje společnost QSAM Biosciences?

QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.

Firmy s metrikou zisková marže podobnou společnosti QSAM Biosciences